152 related articles for article (PubMed ID: 24740228)
21. Methodological Variables in the Analysis of Cell-Free DNA.
Bronkhorst AJ; Aucamp J; Pretorius PJ
Adv Exp Med Biol; 2016; 924():157-163. PubMed ID: 27753037
[TBL] [Abstract][Full Text] [Related]
22. Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood.
Samoila A; Sosa J; Padilla J; Wutkowski M; Vanness K; Viale A; Berger M; Houck-Loomis B; Pessin M; Peerschke EI
J Appl Lab Med; 2020 Jul; 5(4):788-797. PubMed ID: 32603443
[TBL] [Abstract][Full Text] [Related]
23. Mutant form of BRAF gene in blood plasma of cancer patients.
Vdovichenko KK; Markova SI; Belokhvostov AS
Ann N Y Acad Sci; 2004 Jun; 1022():228-31. PubMed ID: 15251965
[No Abstract] [Full Text] [Related]
24. Medicine. Keeping tabs on tumor DNA.
Kaiser J
Science; 2010 Feb; 327(5969):1074. PubMed ID: 20185705
[No Abstract] [Full Text] [Related]
25. Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations.
Pinzani P; Salvianti F; Zaccara S; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2011 Nov; 412(23-24):2141-5. PubMed ID: 21839068
[TBL] [Abstract][Full Text] [Related]
26. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum.
Jen J; Wu L; Sidransky D
Ann N Y Acad Sci; 2000 Apr; 906():8-12. PubMed ID: 10818587
[TBL] [Abstract][Full Text] [Related]
27. Detection of Circulating Tumor DNA in the Blood of Cancer Patients: An Important Tool in Cancer Chemoprevention.
Ulz P; Auer M; Heitzer E
Methods Mol Biol; 2016; 1379():45-68. PubMed ID: 26608289
[TBL] [Abstract][Full Text] [Related]
28. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection.
Pantel K
PLoS Med; 2016 Dec; 13(12):e1002205. PubMed ID: 28027295
[TBL] [Abstract][Full Text] [Related]
29. Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab.
Steffensen KD; Madsen CV; Andersen RF; Waldstrøm M; Adimi P; Jakobsen A
Eur J Cancer; 2014 Oct; 50(15):2611-8. PubMed ID: 25087181
[TBL] [Abstract][Full Text] [Related]
30. Influence of plasma processing on recovery and analysis of circulating nucleic acids.
Page K; Guttery DS; Zahra N; Primrose L; Elshaw SR; Pringle JH; Blighe K; Marchese SD; Hills A; Woodley L; Stebbing J; Coombes RC; Shaw JA
PLoS One; 2013; 8(10):e77963. PubMed ID: 24205045
[TBL] [Abstract][Full Text] [Related]
31. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
32. The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics.
Jiang P; Lo YMD
Trends Genet; 2016 Jun; 32(6):360-371. PubMed ID: 27129983
[TBL] [Abstract][Full Text] [Related]
33. TP53 gene in blood plasma DNA of tumor patients.
Schlechte HH; Stelzer C; Weickmann S; Fleischhacker M; Schulze G
Ann N Y Acad Sci; 2004 Jun; 1022():61-9. PubMed ID: 15251941
[TBL] [Abstract][Full Text] [Related]
34. Assessment of DNA Integrity, Applications for Cancer Research.
Zonta E; Nizard P; Taly V
Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.
Mauger F; Dulary C; Daviaud C; Deleuze JF; Tost J
Anal Bioanal Chem; 2015 Sep; 407(22):6873-8. PubMed ID: 26123439
[TBL] [Abstract][Full Text] [Related]
36. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
[TBL] [Abstract][Full Text] [Related]
37. Circulating DNA in plasma or serum.
Anker P; Stroun M
Medicina (B Aires); 2000; 60(5 Pt 2):699-702. PubMed ID: 11188885
[TBL] [Abstract][Full Text] [Related]
38. The tumour trail left in blood.
Chi KR
Nature; 2016 Apr; 532(7598):269-71. PubMed ID: 27075102
[No Abstract] [Full Text] [Related]
39. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
40. Features of Circulating DNA Fragmentation in Blood of Healthy Females and Breast Cancer Patients.
Tamkovich SN; Kirushina NA; Voytsitskiy VE; Tkachuk VA; Laktionov PP
Adv Exp Med Biol; 2016; 924():47-51. PubMed ID: 27753018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
